<p>Kaplan-Meier curve depicting the statistically significant (p = 0.01, log rank test) difference in the overall survival for the 38 primary DLBCL patients treated with R-CHOP. Tumors were grouped by MYC IHC score >50% (n = 6) or ≤50% (n = 32).</p
<p>Squares represent the HR of each study, and the area of each square was proportional to the weigh...
<p>(A, B) OS (A) and PFS (B) of patients with MYC/BCL2 DHS. (C, D) OS (C) and PFS (D) of patients wi...
<p>(A, B) OS (A) and PFS (B) of all patients treated with CHOP or R-CHOP. (C, D) OS (C) and PFS (D) ...
<p>Patients’ tumors were stained for (A, B) MYC, (C, D) BCL2, (E, F) BCL6, and (G, H) Ki67. The numb...
<p>Patients’ tumors were stained for (A, B) MYC, (C, D) BCL2, (E, F) BCL6, and (G, H) Ki67. The numb...
<p>(<b>A</b>). Comparison of percent MYC positive tumor nuclei for Burkitt lymphoma, reactive tonsil...
<p>Kaplan Meier curves represents OS according to A) MYC protein expression, B) FOXP1 protein expres...
<p>(A) Patients bearing CXCR7+ tumors showed significantly higher OS than patients bearing CXCR7- tu...
<p>(A, B) OS (A) and PFS (B) of patients with MYC/BCL2 DHS. (C, D) OS (C) and PFS (D) of patients wi...
This study examined the reproducibility of MYC and BCL-2 immunohistochemical scoring as well as the ...
This journal issue is proceedings of ASH Conference 2012Open Access JournalOral Sessions - 622. Non-...
1)<p>MYC High cases show positive staining for MYC in >50% of tumor nuclei; MYC Low cases show posit...
Introduction. C-MYC is one of the essential transcription factors that play a role in various cellul...
<div><p>Recent studies provide convincing evidence that a combined immunohistochemical or fluorescen...
<p>Overall survival curves for patients according to the negative (n = 57) and positive (n = 66) exp...
<p>Squares represent the HR of each study, and the area of each square was proportional to the weigh...
<p>(A, B) OS (A) and PFS (B) of patients with MYC/BCL2 DHS. (C, D) OS (C) and PFS (D) of patients wi...
<p>(A, B) OS (A) and PFS (B) of all patients treated with CHOP or R-CHOP. (C, D) OS (C) and PFS (D) ...
<p>Patients’ tumors were stained for (A, B) MYC, (C, D) BCL2, (E, F) BCL6, and (G, H) Ki67. The numb...
<p>Patients’ tumors were stained for (A, B) MYC, (C, D) BCL2, (E, F) BCL6, and (G, H) Ki67. The numb...
<p>(<b>A</b>). Comparison of percent MYC positive tumor nuclei for Burkitt lymphoma, reactive tonsil...
<p>Kaplan Meier curves represents OS according to A) MYC protein expression, B) FOXP1 protein expres...
<p>(A) Patients bearing CXCR7+ tumors showed significantly higher OS than patients bearing CXCR7- tu...
<p>(A, B) OS (A) and PFS (B) of patients with MYC/BCL2 DHS. (C, D) OS (C) and PFS (D) of patients wi...
This study examined the reproducibility of MYC and BCL-2 immunohistochemical scoring as well as the ...
This journal issue is proceedings of ASH Conference 2012Open Access JournalOral Sessions - 622. Non-...
1)<p>MYC High cases show positive staining for MYC in >50% of tumor nuclei; MYC Low cases show posit...
Introduction. C-MYC is one of the essential transcription factors that play a role in various cellul...
<div><p>Recent studies provide convincing evidence that a combined immunohistochemical or fluorescen...
<p>Overall survival curves for patients according to the negative (n = 57) and positive (n = 66) exp...
<p>Squares represent the HR of each study, and the area of each square was proportional to the weigh...
<p>(A, B) OS (A) and PFS (B) of patients with MYC/BCL2 DHS. (C, D) OS (C) and PFS (D) of patients wi...
<p>(A, B) OS (A) and PFS (B) of all patients treated with CHOP or R-CHOP. (C, D) OS (C) and PFS (D) ...